About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Chicago | 204 Studies

Clinical Trials Pancreatic CancerChicago

Pancreatic Cancer Clinical Trials in Chicago

Find 204 clinical trials for pancreatic cancer near Chicago, Illinois. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 204 trials

CompletedA Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsThis is a Phase 1b/2, multi-center study to assess the safety and efficacy of ibrutinib in combination with durvalumab (MEDI4736) in participants with relapsed or refractory solid…NCT02403271·Birmingham, Alabama and 16 others Completed131-I-TM-601 Study in Adults With Solid TumorsThis study is designed to evaluate the ability of intravenously (IV)administered 131-I-labeled TM-601 (chlorotoxin) to provide tumor-specific localization(via radiographic…NCT00379132·Birmingham, Alabama and 5 others RecruitingAPOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationThis phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been…NCT04858334·Anchorage, Alaska and 453 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEvaluation of Multiple Needle Use in EUS-FNA for Pancreatic CancerThe aim of this study is to evaluate if the early change of needle during EUS-FNA for suspected pancreatic cancer allows an earlier preliminary cytological diagnosis of neoplasia.NCT00548626·Chicago, Illinois

CompletedEndoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionRATIONALE: The use of endoscopy to place metal stents in the duodenum is less invasive than surgery for treating cancer-related duodenal obstruction and may have fewer side…NCT00004910·Chicago, Illinois

Terminated(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic CancerThis Phase Ib dose escalation study will evaluate BTH1704, a monoclonal antibody that targets an aberrantly glycosylated antigen Mucin 1, and Imprime PGG, a glucan contained in…NCT02132403·Chicago, Illinois

RecruitingStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesThis study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer…NCT05417594·La Jolla, California and 31 others

CompletedGemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic CancerThis randomized phase I/II trial studies gemcitabine hydrochloride and vismodegib to see how well they work compared with gemcitabine hydrochloride alone in treating patients with…NCT01064622·Beverly Hills, California and 24 others

CompletedA Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk GroupsPanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups.NCT03693378·Stanford, California and 20 others

CompletedStudy of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic CancerThe purpose of this study is to learn about the safety and potential benefit of metronomic 5-fluorouracil in combination with nab®1-paclitaxel, bevacizumab, leucovorin, and…NCT02620800·Chicago, Illinois and 6 others

TerminatedLong Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) ImmunotherapyThis protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate…NCT03165188·Los Angeles, California and 14 others

Active not recruitingNivolumab and Ipilimumab in Treating Patients With Rare TumorsThis phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors.NCT02834013·Birmingham, Alabama and 1006 others

CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionPhase I trial to study the effectiveness of erlotinib in treating patients who have metastatic or unresectable solid tumors and liver or kidney dysfunction.NCT00030498·Chicago, Illinois

TerminatedRO4929097 Before Surgery in Treating Patients With Pancreatic CancerThis phase I trial is studying the side effects of RO4929097 before surgery in treating patients with pancreatic cancer.NCT01192763·Beverly Hills, California and 5 others

CompletedRapamycin With Grapefruit Juice for Advanced MalignanciesThe purpose of this study is to determine the highest safe dose of rapamycin when given with a fixed amount of grapefruit juice.NCT00375245·Chicago, Illinois

Approved for marketingExpanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationExpanded access for participants with cancer with RET activation who are ineligible for an ongoing selpercatinib (also known as LOXO-292) clinical trial or have other…NCT03906331·Goodyear, Arizona and 63 others

CompletedFOLFIRINOX Plus IPI-926 for Advanced Pancreatic AdenocarcinomaThe purpose of this phase I study to determine the optimal dose for the combination of IPI-926 plus FOLFIRINOX (5-fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin)…NCT01383538·San Francisco, California and 2 others

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

CompletedAdjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00059826·Gainesville, Florida and 13 others

CompletedStudy Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the PancreasA prospective, multicenter, open label, randomized phase III study to evaluate efficacy and safety of FFX versus CPI-613 + mFFX in patients with metastatic adenocarcinoma of the…NCT03504423·Gilbert, Arizona and 73 others

PreviousPage 2 of 11Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia